Market valuation and wound care markets in context

Critical appraisal of research & innovation
.....
Covering all major areas including…
Moist Wound Dressings
Growth Factors
Skin Replacement/Skin Substitutes
Antimicrobial Silver Dressings
Collagen Dressings
Other Matrix Protein Dressings
Honey-Based Dressings
Negative Pressure Wound Therapy
Oxygen Therapies The global wound care market is estimated to be worth US$7.2 billion in 2006 and comprises two sectors, traditional and advanced.

Traditional wound care products consist mainly of low technology gauze-based dressings such as woven and non-woven sponges, conforming bandages and non-adherent bandages. While effective in certain wound management environments, industry and commercial interest is focused on the wide range of new, advanced wound care products and treatments that are coming to market.

The advanced wound care segment encompasses a wide range of disparate technologies that fall into three main categories:

Moist wound dressings (hydrogels, hydrocolloids, alginates, foams and transparent films);

Antimicrobial dressings which deliver substances such as silver to the wound;

Biological products such as skin substitutes, tissue-engineered products and growth factors.

In addition, a growing number of wound-healing devices such as negative pressure wound therapy (NPWT) are becoming more prominent. The sector also includes a variety of other treatments such as oxygen therapy, electrical stimulation; low level laser therapy (LLLT), therapeutic ultrasound and maggot therapy.

The US$4.1 billion global advanced wound care segment is the fastest growing area with double-digit growth of 10% per year. This growth is being driven by an ageing population, the rise in the incidence of diabetes worldwide and a steady advancement in technology and products that are more clinically efficient and cost effective than their conventional counterparts.

Few areas of medical research are developing such a wide variety of novel clinical approaches, from the most up-to-date tissue regeneration technology to natural cures.

A common issue facing all developers, and one which is limiting growth, is the disparity in reimbursement levels. Often valuing the product at cost and ignoring the cost- efficiency benefits of faster recovery times, health payers are playing a role in determining market expansion. This is more apparent in the US market which, unusually, is the second market of interest after Europe.

An increasing medical need
Elderly people, diabetics, immunosuppressed and immobilised individuals have an increased incidence of chronic wounds and other dermal afflictions that result from poor circulation and immobility, e.g. pressure ulcers (bed sores), venous stasis ulcers, and diabetic ulcers. These chronic conditions greatly increase the cost of care and reduce the patient's quality of life. As these groups are growing in number, the need for advanced wound care products will increase.

Domination or innovation?
While this highly competitive sector includes the big multinationals among its market leaders, a relatively new player, Kinetic Concepts, is the overall advanced wound care market leader with its V.A.C. negative pressure wound therapy system, having overtaken Smith & Nephew in the last two years. Smith & Nephew remains the world market leader in the wound dressing segment. Much of the innovation is however being created by smaller companies. Who are they, how do they fit into the competitive environment and what are their products and research portfolios like?

A management report which provides real answers
The answer to these questions can be found in the extensive 280-page report The Global Market for Advanced Wound Care Products 2007. The report is divided into two sections:

SECTOR ANALYSIS
The first examines the sector by technology type and assesses the competing products.

COMPANY PROFILES
The second section provides company profiles which examine financial performance or funding, identifies key alliances and looks at research and product portfolios.

THE COMPANIES COVERED

¨ 3M
¨ AcryMed
¨ Advanced BioHealing
¨ Agennix
¨ AGT Sciences
¨ Alltracel
¨ APR Applied Pharma Research
¨ Argentum Medical
¨ Ark Therapeutics
¨ Bard Medical
¨ BioCore Medical Technologies
¨ Biofisica
¨ BioSyntech
¨ BlueSky Medical
¨ B. Braun
¨ Brennen Medical
¨ Care-Tech Laboratories
¨ Carrington Laboratories
¨ CellTran
¨ Clinical Cell Culture (C3)
¨ CoDa Therapeutics
¨ Collagen Matrix
¨ Coloplast
¨ Comvita NZ
¨ ConvaTec
¨ Covalon Technologies
¨ Cytomedix
¨ Derma Sciences
¨ DeRoyal
¨ Ferris
¨ Fidia Advanced Biopolymers
¨ First Water
¨ Gentell
¨ Genzyme Biosurgery
¨ Global Health Products
¨ Hartmann Group
¨ HealOr
¨ Healthpoint
¨ Helix Biomedix
¨ Hollister
¨ Innocoll
¨ Insense
¨ Invacare Supply Group
¨ Integra LifeSciences
¨ Ivivi Technologies
¨ IYIA Technologies
¨ Johnson & Johnson
¨ Kendall Healthcare
¨ Kinetic Concepts
¨ Laboratoires Brothier
¨ Laboratoires Genévrier
¨ Lescarden
¨ LifeCell
¨ Magnus Bio-Medical Technologies
¨ Medical Nutrition USA
¨ Medical Quant
¨ Medihoney
¨ Medline Industries
¨ Milliken Chemical
¨ Mölnlycke Health Care
¨ Organogenesis
¨ Ortec International
¨ Pegasus Biologics
¨ Promethean LifeSciences
¨ Quick-Med Technologies
¨ RegeneRx Biopharmaceuticals
¨ SafeBlood Technologies
¨ Smith & Nephew
¨ Southwest Technologies
¨ Tissue Genesis
¨ UDL Laboratories
¨ Unomedical
¨ Urgo
¨ Wound Care Innovations
¨ Wright Medical Group
¨ Xilas Medical
¨ ZooBiotic